Compare Docusign Inc (DOCU) vs Freeport-McMoRan Inc (FCX) Price & Performance

DocuSign (DOCU) trades at $64.09, up 8.0% in the last 24 hours, reflecting strong momentum. The stock shows bullish technical signals with moving averages supporting an uptrend. Fundamentally, the company reported revenue of $2.98 billion in 2025 with a net income of $1.07 billion, marking a significant turnaround from prior losses. Recent quarters have consistently beaten EPS estimates, including Q1 2026's actual $1.09 versus $0.994 expected. However, cash flow trends show net outflows, and the CFO's recent share sale of $900,000 on August 7, 2026 (The Motley Fool) adds caution.

Outlook is mixed: robust earnings growth and high gross margins of 79.4% support upside, but valuation ratios like a P/E of 37.73 suggest premium pricing. Risks include competitive pressures and cash flow volatility. Analysts are mostly neutral with a consensus price target of $55.40, below the current price, indicating potential overvaluation. Investors should weigh strong fundamentals against high expectations and insider selling trends.

FCX trades at $66.83, down 2.98% on the day, but maintains a bullish technical trend with strong analyst support. The company has beaten earnings estimates for three consecutive quarters, with Q3 2026 expected at $0.72 EPS. Revenue remains stable around $25.9B, while net income margin improved to 11.38% in 2026. Recent news highlights operational challenges like lower copper volumes but also growth initiatives at Grasberg and Bagdad.

The outlook is positive with a consensus price target of $73.85, implying ~10% upside. Key opportunities include exposure to high copper prices and expansion projects, while risks involve production volatility, cost pressures, and reliance on commodity cycles. The stock's valuation appears elevated with a P/E of 33.93, requiring sustained earnings growth to justify further gains.